Dr. Kinchelow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
471 E Saddle River Rd
Ridgewood, NJ 07450Phone+1 201-925-2400Fax+1 201-612-1104
Education & Training
New York Medical College at St Michael's Medical CenterFellowship, Infectious Disease, 1979 - 1981- New York Medical College at St Michael's Medical CenterResidency, Internal Medicine, 1976 - 1979
Rutgers New Jersey Medical SchoolClass of 1976
Certifications & Licensure
NJ State Medical License 1978 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 58 citationsSafety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.Benoit Trottier, Sharon Walmsley, Jacques Reynes, Peter J. Piliero, Mary O'Hearn
Journal of Acquired Immune Deficiency Syndromes. 2005-12-01 - 20 citationsLack of Interaction between Enfuvirtide and Ritonavir or Ritonavir‐Boosted Saquinavir in HIV‐1‐Infected PatientsKiat Ruxrungtham, Mark A. Boyd, S. Eralp Bellibas, Xiaoping Zhang, Albert Dorr
Journal of Clinical Pharmacology. 2004-07-01 - 31 citationsAssessment of Drug‐drug Interaction Potential of Enfuvirtide in Human Immunodeficiency Virus Type 1–infected PatientsXiaoping Zhang, Jacob P. Lalezari, Andrew D. Badley, Albert Dorr, Stanley J. Kolis
Clinical Pharmacology and Therapeutics. 2004-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
